Skip to main content
BenevolentAI logo

BenevolentAI — Investor Relations & Filings

Ticker · BAI ISIN · LU2355630455 LEI · 2221003P54KEDC3P4Z33 AS Professional, scientific and technical activities
Open in API
Filings indexed 65 across all filing types
Latest filing 2022-04-22 M&A Activity
Country LU Luxembourg
Listing AS BAI

About BenevolentAI

https://www.benevolent.com/

BenevolentAI is a clinical-stage company that specializes in applying artificial intelligence (AI) and machine learning to drug discovery and development. The company utilizes its proprietary technology platform, which is built upon a comprehensive knowledge graph, to analyze vast amounts of complex biomedical information. This platform is designed to generate novel biological insights, identify new therapeutic targets, and accelerate the research and development process for new medicines. By integrating advanced AI with scientific expertise, BenevolentAI aims to decipher complex disease biology and improve the efficiency and success rate of bringing new treatments to patients.

Recent filings

Filing Released Lang Actions
Alchemy - Press Release (Completion of Business Combination)
M&A Activity Classification · 1% confidence The document is a press release announcing the successful completion of a business combination (merger) between Odyssey Acquisition S.A. and BenevolentAI Limited, resulting in a name change and significant share capital adjustments. It details the issuance of new shares, conversion of sponsor shares, and the approval of a prospectus for listing on Euronext Amsterdam. This event—a major corporate transaction involving the combination of two entities and subsequent capital structure changes—is characteristic of a significant corporate action announcement. While it mentions a prospectus being approved, the primary focus is the completion of the M&A transaction itself. The closest fit among the provided codes is 'M&A Activity' (TAR), as it details the finalization of the business combination/merger. It is not a standard 10-K, ER, or IR, nor is it merely an announcement of a report (RPA/RNS), as it contains substantive details about the transaction's completion and resulting capital structure.
2022-04-22 English
Odyssey Acquisition S.A. EGM 11 April 2022 - Press Release
AGM Information Classification · 1% confidence The document is a press release announcing that Odyssey Acquisition S.A. obtained shareholder approval at an Extraordinary General Meeting (EGM) for its business combination with BenevolentAI. It details the voting results (91.89% approval), the expected cash proceeds (€225m), and the approval of new board members effective upon closing. The key phrases are 'shareholder approval', 'EGM', 'business combination', and the announcement of voting results. This strongly indicates a filing related to the outcome of a shareholder vote, which aligns with the Declaration of Voting Results & Voting Rights Announcements (DVA). While it mentions the EGM, it is reporting the *results* of the vote, not the proxy materials (PSI) or the AGM presentation itself (AGM-R). It is not a full 10-K, ER, or IR. Since DVA is a specific category for vote results, it is the most appropriate classification.
2022-04-11 English
CSSF filing - Mr. Michael Zaoui amended and signed 11032022
Director's Dealing Classification · 1% confidence The document is titled "Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them." It details specific transactions (Subscription of shares and Warrants) made by a director (Mr. Michael Zaoui, Chairman of the Board of Directors) of the issuer (Odyssey Acquisition S.A.). This content directly corresponds to the definition of Director's Dealing, which involves reporting personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2022-03-14 English
BAI Odyssey New Equity Commitments FINAL
Capital/Financing Update Classification · 1% confidence The document is a press release dated March 3, 2022, announcing new equity commitments (€60M) for the business combination between Odyssey Acquisition S.A. (a SPAC) and BenevolentAI. It details financing agreements (backstop and non-redemption commitments) and amends the minimum cash condition for the merger. This content directly relates to fundraising, capital structure changes, and the mechanics of a business combination involving a SPAC. This aligns best with the 'Capital/Financing Update' category (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it concerns a specific corporate finance event.
2022-03-03 English
Alchemy - Odyssey Acquisition SA - Press Release 15122021 - Final
M&A Activity Classification · 1% confidence The document is a press release dated December 15, 2021, announcing a significant business development: BenevolentAI achieving a major collaboration milestone with AstraZeneca regarding a novel drug target for idiopathic pulmonary fibrosis (IPF). It also mentions a prior announcement regarding a business combination (merger) between Odyssey Acquisition S.A. and BenevolentAI. The text contains extensive disclaimers typical of corporate announcements related to securities and future performance, and it is explicitly labeled as a 'Public disclosure of inside information in accordance with article 17(1) of the Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation)'. This type of disclosure, which is a formal announcement of material, non-public information, often falls under general regulatory filing categories when it doesn't fit a specific financial report type (like 10-K or ER). Since it is a formal, market-sensitive announcement that doesn't fit the definitions for Earnings Release (ER), Interim Report (IR), or a specific capital event (CAP, SHA), the most appropriate general category for a mandatory regulatory disclosure of this nature, especially one concerning market abuse regulation compliance, is Regulatory Filings (RNS). It is not an announcement of a report being published (RPA), but the content itself is the disclosure.
2021-12-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.